Relebactam
Records for this ingredient, by country (identity only).
ATC — · 8 markets · 8 records
US 1 records · 1 shown of 1
Combination products containing this ingredient
- 250 mg/100 mLinjection CombinationCilastatin 500 mg/100 mL + Imipenem 500 mg/100 mL + Relebactam 250 mg/100 mLRECARBRIO
GB 1 records · 1 shown of 1
Combination products containing this ingredient
- 250 mg per mL / per unit basis not statedinjection CombinationCilastatin 500 mg + Imipenem 500 mg + Relebactam 250 mgRecarbrio 500mg/500mg/250mg powder for solution for infusion vials
CA 1 records · 1 shown of 1
Combination products containing this ingredient
- 250 mgpowder CombinationCilastatin 500 mg + Imipenem 500 mg + Relebactam 250 mgRECARBRIO
ES 1 records · 1 shown of 1
Combination products containing this ingredient
- 250 mg per mL / per unit basis not statedinjection CombinationCilastatin 500 mg + Imipenem 500 mg + Relebactam 250 mgRECARBRIO
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | ES | TW | JP | EU | FR |
|---|---|---|---|---|---|---|---|---|
| 250 mg per mL / per unit basis not stated cannot compare Combination Cilastatin 500 mg + Imipenem 500 mg + Relebactam 250 mg injection | Recarbrio 500mg/500mg/250mg powder for solution for infusion vials | RECARBRIO | ||||||
| 250 mg/100 mL Combination Cilastatin 500 mg/100 mL + Imipenem 500 mg/100 mL + Relebactam 250 mg/100 mL injection | RECARBRIO | |||||||
| 250 mg Combination Cilastatin 500 mg + Imipenem 500 mg + Relebactam 250 mg powder | RECARBRIO | |||||||
| Combination Cilastatin + Imipenem + Relebactam injection | RECARBRIO Powder for solution for infusion 瑞必優 乾粉注射劑 | レカルブリオ配合点滴静注用 | RECARBRIO 500 mg/500 mg/250 mg, poudre pour solution pour perfusion | |||||
| Combination Cilastatin + Imipenem + Relebactam unknown | RECARBRIO |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in GB · ES · EU and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en GB · ES · EU que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 GB · ES · EU 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 GB · ES · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.